LAG3 and acute myeloid leukemia: Anti-LAG3 antibody attenuated this immunosuppression by increasing the number of activated T cells and cytotoxic cytokines, decreasing T-reg cells, and enhancing MHC-I mediated killing of AML cells, thus supporting the inhibition of LAG3 as a means to mitigating AML immunosuppressive effect (21).